S9191 — Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies
Last action — In Senate Committee
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed Assembly
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced February 12, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill limits control between insurance companies, pharmacy benefits managers, and pharmacies.
This legislation imposes restrictions on insurance companies and pharmacy benefits managers, mandating their divestment from overlapping interests and barring payment from certain state programs for violations. It aims to reduce conflicts of interest in the healthcare system.
What this means for you
- Healthcare: This means healthcare entities may need to adjust their business practices to comply with new control limitations.
Summary
Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers; prohibits insurance companies, pharmacies, and pharmacy benefit managers found in violation of such provisions from receiving payment from certain state programs.
Bill Text
- Full text View text Current
Action History
-
PRINT NUMBER 9191A
-
AMEND AND RECOMMIT TO JUDICIARY
-
REFERRED TO JUDICIARY
Sponsors
- Michelle Hinchey · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S9191 do?
- Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers; prohibits insurance companies, pharmacies, and pharmacy benefit managers found in violation of such provisions from receiving payment from certain state programs.
- Who sponsors S9191?
- S9191 is sponsored by Michelle Hinchey.
- What is the current status of S9191?
- This bill has been introduced in the Senate. Introduced February 12, 2026. It must pass committee before a floor vote.
- Where can I track S9191?
- Track S9191 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S9191
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S9191
Last checked for changes 11 days ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →